Full-Time

Director – Engineering and Data Governance-Clinical

Quality and regulatory

Confirmed live in the last 24 hours

Vertex Pharmaceuticals

Vertex Pharmaceuticals

1,001-5,000 employees

Develops medicines for serious diseases

Compensation Overview

$184k - $276k/yr

+ Bonus + Equity Awards

Senior, Expert

Company Does Not Provide H1B Sponsorship

Boston, MA, USA

Hybrid-Eligible: work remotely up to two days per week; or work five days per week on-site with ad hoc flexibility.

Category
Legal
Risk & Compliance
Legal & Compliance
Required Skills
Agile
Visio
AWS
Databricks
Data Analysis
Snowflake
Excel/Numbers/Sheets
PowerPoint/Keynote/Slides
Requirements
  • Strong knowledge and experience with leading and managing data, reporting and analytics projects and assets for the clinical, quality and regulatory domains in the biopharmaceutical industry.
  • In-depth knowledge of foundational and business process data sets in the clinical, quality and regulatory business areas.
  • Working knowledge and experience in the clinical, quality and regulatory functional areas and the related business processes.
  • Strong understanding of data management, data governance, data architecture, software engineering, and cloud computing.
  • Strong communication and presentation skills, with the ability to communicate technical and non-technical topics to senior leaders and engineering teams.
  • Proven ability to serve as a control function and enforce annual planning agreements by finding ways to say “yes” to prioritized commitments and “no” to lower priority requests.
  • Strong understanding and awareness of data privacy, data security and compliance to relevant rules including GxP regulations.
  • Advanced analytical, problem solving, negotiation and organizational skills with demonstrated ability to multi-task, organize, prioritize, and meet deadlines.
  • Strong knowledge of modern technologies like cloud computing, cybersecurity, data platforms like AWS, Snowflake and Databricks.
  • Project management, demand management, resource management and system life cycle expertise.
  • Prior experience with running IT managed services or outsourced/ offshore teams.
  • Superior MS Office skills, including MS Project & Visio, Excel and PowerPoint Experience.
  • Strong experience in Agile methodology.
  • Bachelor's degree required (preferably in a technology or engineering discipline).
  • 10+ years’ experience working in growing technology roles with at least 6 years in IT leadership positions.
  • 6+ years’ experience in a similar governance, planning, or strategy role with a focus on bio pharma.
Responsibilities
  • Partner with DTE Leadership to develop and execute data and analytics strategy aligned to the clinical, quality and regulatory business strategy and develop data and analytics roadmaps to enable the data strategy.
  • Collaborate with portfolio managers, platform owners, and business engagement leads to identify data and software solutions that satisfy prioritized business needs and drive innovation in investment strategies and timing.
  • Collaborate with cross-functional teams to define data and custom software requirements and contribute to solution designs that deliver the expected business capabilities.
  • Oversee the management, documentation, use, and quality assurance processes for prioritized data projects and data assets, including proprietary data sets, third party data, clinical, regulatory and quality data.
  • Collaborate with cross-functional teams to communicate engineering and data governance standards, frameworks, and data management processes and assist with data governance enablement for the clinical, quality and regulatory functions.
  • Ensure the successful leadership and management of data and custom software development initiatives and projects, including prioritization, planning, requirements, execution, monitoring, communication, and evaluation.
  • Collaborate with stakeholders to define project goals, deliverables, timelines, budgets, and resource requirements.
  • Collaborate with resource managers to source, allocate and assign internal or contingent workers to project and operational activities.
  • Monitor project and platform progress, manage risks, and communicate updates to key stakeholders, ensuring successful and timely project delivery.
  • Collaborate with DTE domain experts, learning about the clinical, quality and regulatory business areas and understanding how data and custom software add value to Vertex’s priorities.
  • Collaborate with cross-functional DTE and business teams, including portfolio management, privacy, security, business engagement, HR, DSS and DCS to ensure data and software development needs are understood and solutions are aligned with prioritized business objectives.
Vertex Pharmaceuticals

Vertex Pharmaceuticals

View

Vertex Pharmaceuticals develops medicines for serious diseases, focusing on conditions like cystic fibrosis. The company conducts extensive research and development to create new drugs, often collaborating with other biotech firms to enhance its therapeutic offerings. One of its notable products is ivacaftor, which has shown effectiveness in treating cystic fibrosis. Vertex differentiates itself from competitors through its commitment to scientific innovation and strategic partnerships that expand its research capabilities. The goal of Vertex Pharmaceuticals is to improve the quality of life for patients with severe and life-threatening conditions by bringing effective treatments to market.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Boston, Massachusetts

Founded

1989

Simplify Jobs

Simplify's Take

What believers are saying

  • Vertex's EU approval expands its cystic fibrosis treatment market.
  • Partnerships with Arbor and Orna enhance Vertex's gene therapy capabilities.
  • Increased focus on personalized medicine aligns with Vertex's patient-centric approach.

What critics are saying

  • Increased competition in cystic fibrosis could impact Vertex's market share.
  • Regulatory changes in the EU may delay Vertex's drug approvals.
  • High R&D costs and potential trial failures could strain Vertex's finances.

What makes Vertex Pharmaceuticals unique

  • Vertex focuses on transformative medicines for serious diseases, like cystic fibrosis.
  • The company invests heavily in R&D and strategic partnerships for drug development.
  • Vertex's innovative cell and gene therapies set it apart in the biotech industry.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Hybrid Work Options

Company News

Buniversity
May 1st, 2025
VERTEX upset Grayhound for spot at BLAST Showdown

VERTEX locked in a first-place finish at Fortress OCE Masters Fall 2022 Finals in Melbourne to qualify for BLAST Premier Fall Showdown.

BioSpace
Apr 14th, 2025
Vertex Researcher, Paul Negulescu Ph.D., Receives the 2025 Canada Gairdner International Award for Pioneering Research and Discovery of Medicines for Cystic Fibrosis

Vertex researcher, Paul Negulescu Ph.D., receives the 2025 Canada Gairdner International Award for pioneering Research and discovery of medicines for Cystic Fibrosis.

Biz Owner Daily
Apr 7th, 2025
EU Approves Expanded Label for Vertex Pharmaceuticals' Cystic Fibrosis Treatment

Vertex Pharmaceuticals has received approval from the European Union to broaden the label for its cystic fibrosis treatment.

Slater Sentinel
Mar 23rd, 2025
Stevens Capital Management LP Makes New $829,000 Investment in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)

Stevens Capital Management LP makes new $829,000 investment in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX).

Investing.com
Mar 20th, 2025
BMO maintains Vertex stock Market Perform rating and $41 target

The reaffirmation of the rating and target came after Vertex held its first analyst day since its initial public offering in 2020.